Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
132.86
+0.05 (0.04%)
Aug 19, 2025, 4:00 PM - Market open
Neurocrine Biosciences Analyst Ratings
Total Analysts
19
Consensus Rating
Strong Buy
Price Target
$162.42
Upside
+22.25%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Maintains $165 → $175 | Strong Buy | Maintains | $165 → $175 | +31.72% | Aug 1, 2025 |
JP Morgan | JP Morgan | Hold Maintains $140 → $145 | Hold | Maintains | $140 → $145 | +9.14% | Jul 31, 2025 |
RBC Capital | RBC Capital | Buy Maintains $146 → $144 | Buy | Maintains | $146 → $144 | +8.38% | Jul 31, 2025 |
Stifel | Stifel | Strong Buy Maintains $166 → $174 | Strong Buy | Maintains | $166 → $174 | +30.96% | Jul 31, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $150 → $158 | Buy | Maintains | $150 → $158 | +18.92% | Jul 31, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $154 → $175 | Buy | Maintains | $154 → $175 | +31.72% | Jul 31, 2025 |
Wedbush | Wedbush | Buy Maintains $137 → $141 | Buy | Maintains | $137 → $141 | +6.13% | Jul 31, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $148 → $150 | Buy | Maintains | $148 → $150 | +12.90% | Jul 22, 2025 |
Truist Securities | Truist Securities | Strong Buy Initiates $163 | Strong Buy | Initiates | $163 | +22.69% | Jul 21, 2025 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $182 | Strong Buy | Initiates | $182 | +36.99% | Jul 10, 2025 |
UBS | UBS | Strong Buy Maintains $152 → $174 | Strong Buy | Maintains | $152 → $174 | +30.96% | Jul 9, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $145 | Buy | Reiterates | $145 | +9.14% | Jun 2, 2025 |
Piper Sandler | Piper Sandler | Buy Reiterates $160 → $154 | Buy | Reiterates | $160 → $154 | +15.91% | May 6, 2025 |
RBC Capital | RBC Capital | Buy Maintains $137 → $145 | Buy | Maintains | $137 → $145 | +9.14% | May 6, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $155 → $165 | Strong Buy | Maintains | $155 → $165 | +24.19% | May 6, 2025 |
BMO Capital | BMO Capital | Hold Maintains $96 → $115 | Hold | Maintains | $96 → $115 | -13.44% | May 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.